CRISPR Therapeutics AG (CRSP) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
CRISPR Therapeutics AG (CRSP): 1Y return 45.7%, Sharpe ratio 0.90, volatility 60.2%, max drawdown -42.3%. A Stock in the Equity asset class. Compare CRSP with other assets and invest through your own broker with pfolio.
CRISPR Therapeutics AG (CRSP) Overview
- Type: Stock
- Asset Class: Equity
- Region: Europe
- Country: CH (Developed)
- Currency: USD
CRSP Performance
- MTD
- Return: 19.3%, Sharpe: 10.46, Volatility: 39.6%, Max Drawdown: -1.0%
- YTD
- Return: 8.2%, Sharpe: 0.73, Volatility: 63.8%, Max Drawdown: -28.2%
- 1Y
- Return: 45.7%, Sharpe: 0.90, Volatility: 60.2%, Max Drawdown: -42.3%
- 5Y
- Return: -54.2%, Sharpe: 0.04, Volatility: 59.2%, Max Drawdown: -80.7%
Frequently Asked Questions
- What is CRISPR Therapeutics AG (CRSP)?
- CRISPR Therapeutics AG (CRSP) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does CRSP compare to other assets?
- You can compare CRSP with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in CRSP through pfolio?
- pfolio helps you build diversified portfolios that may include CRSP. You invest through your own broker — pfolio provides the analytics.